APO Research
Talk to an analyst

APO RESEARCH · REPORT

SGLT2 Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global SGLT2 Inhibitor Industry Growth and Trends Forecast to 2032

20 December 202596 pages

Choose your research edition.

Industry ResearchSGLT2 Inhibitor Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal SGLT2 Inhibitor Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal SGLT2 Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SGLT2 Inhibitor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal SGLT2 Inhibitor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global SGLT2 Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for SGLT2 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for SGLT2 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SGLT2 Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SGLT2 Inhibitor include Johnson & Johnson, Merck, Eli Lilly, Pfizer, AstraZeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global SGLT2 Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The SGLT2 Inhibitor market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SGLT2 Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SGLT2 Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global SGLT2 Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

SGLT2 Inhibitor Market by Company

Johnson & Johnson

Merck

Eli Lilly

Pfizer

AstraZeneca

Boehringer Ingelheim

SGLT2 Inhibitor Segment by Type

Dapagliflozin

Empagliflozin

Canagliflozin

Other

SGLT2 Inhibitor Segment by Application

Hospital Pharmacies

Retail Pharmacies

SGLT2 Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SGLT2 Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SGLT2 Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SGLT2 Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of SGLT2 Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of SGLT2 Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dapagliflozin Table 2. Major Company of Empagliflozin Table 3. Major Company of Canagliflozin Table 4. Major Company of Other Table 5. Global SGLT2 Inhibitor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 7. Global SGLT2 Inhibitor Sales Market Share in Volume by Type (2021-2026) Table 8. Global SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 9. Global SGLT2 Inhibitor Sales Market Share in Value by Type (2021-2026) Table 10. Global SGLT2 Inhibitor Price by Type (2021-2026) & (US$/g) Table 11. Global SGLT2 Inhibitor Sales by Type (2027-2032) & (kg) Table 12. Global SGLT2 Inhibitor Sales Market Share in Volume by Type (2027-2032) Table 13. Global SGLT2 Inhibitor Sales by Type (2027-2032) & (US$ Million) Table 14. Global SGLT2 Inhibitor Sales Market Share in Value by Type (2027-2032) Table 15. Global SGLT2 Inhibitor Price by Type (2027-2032) & (US$/g) Table 16. North America SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 17. North America SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 18. Europe SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 19. Europe SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 21. Asia-Pacific SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 23. Latin America SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa SGLT2 Inhibitor Sales by Type (2021-2026) & (kg) Table 25. Middle East and Africa SGLT2 Inhibitor Sales by Type (2021-2026) & (US$ Million) Table 26. SGLT2 Inhibitor Industry Trends Table 27. SGLT2 Inhibitor Industry Drivers Table 28. SGLT2 Inhibitor Industry Opportunities and Challenges Table 29. SGLT2 Inhibitor Industry Restraints Table 30. Global SGLT2 Inhibitor Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global SGLT2 Inhibitor Revenue Market Share by Company (2021-2026) Table 32. Global SGLT2 Inhibitor Sales by Company (2021-2026) & (kg) Table 33. Global SGLT2 Inhibitor Sales Share by Company (2021-2026) Table 34. Global SGLT2 Inhibitor Market Price by Company (2021-2026) & (US$/g) Table 35. Global SGLT2 Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global SGLT2 Inhibitor Major Company Production Sites and Headquarters Table 37. Global SGLT2 Inhibitor Company, Product Type & Application Table 38. Global SGLT2 Inhibitor Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global SGLT2 Inhibitor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global SGLT2 Inhibitor Sales by Region (2021-2026) & (kg) Table 43. Global SGLT2 Inhibitor Sales Market Share in Volume by Region (2021-2026) Table 44. Global SGLT2 Inhibitor Sales by Region (2021-2026) & (US$ Million) Table 45. Global SGLT2 Inhibitor Sales Market Share in Value by Region (2021-2026) Table 46. Global SGLT2 Inhibitor Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 47. Global SGLT2 Inhibitor Sales by Region (2027-2032) & (kg) Table 48. Global SGLT2 Inhibitor Sales Market Share in Volume by Region (2027-2032) Table 49. Global SGLT2 Inhibitor Sales by Region (2027-2032) & (US$ Million) Table 50. Global SGLT2 Inhibitor Sales Market Share in Value by Region (2027-2032) Table 51. Global SGLT2 Inhibitor Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 52. Global SGLT2 Inhibitor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 54. Global SGLT2 Inhibitor Sales Market Share in Volume by Application (2021-2026) Table 55. Global SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 56. Global SGLT2 Inhibitor Sales Market Share in Value by Application (2021-2026) Table 57. Global SGLT2 Inhibitor Price by Application (2021-2026) & (US$/g) Table 58. Global SGLT2 Inhibitor Sales by Application (2027-2032) & (kg) Table 59. Global SGLT2 Inhibitor Sales Market Share in Volume by Application (2027-2032) Table 60. Global SGLT2 Inhibitor Sales by Application (2027-2032) & (US$ Million) Table 61. Global SGLT2 Inhibitor Sales Market Share in Value by Application (2027-2032) Table 62. Global SGLT2 Inhibitor Price by Application (2027-2032) & (US$/g) Table 63. North America SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 64. North America SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 65. Europe SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 66. Europe SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 68. Asia-Pacific SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 70. Latin America SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa SGLT2 Inhibitor Sales by Application (2021-2026) & (kg) Table 72. Middle East and Africa SGLT2 Inhibitor Sales by Application (2021-2026) & (US$ Million) Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Johnson & Johnson SGLT2 Inhibitor Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Merck SGLT2 Inhibitor Product Portfolio Table 82. Merck Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Eli Lilly SGLT2 Inhibitor Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Pfizer SGLT2 Inhibitor Product Portfolio Table 92. Pfizer Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. AstraZeneca SGLT2 Inhibitor Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Boehringer Ingelheim Company Information Table 99. Boehringer Ingelheim Business Overview Table 100. Boehringer Ingelheim SGLT2 Inhibitor Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Boehringer Ingelheim SGLT2 Inhibitor Product Portfolio Table 102. Boehringer Ingelheim Recent Development Table 103. North America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 104. North America SGLT2 Inhibitor Sales by Country (2021-2026) & (kg) Table 105. North America SGLT2 Inhibitor Sales Market Share by Country (2021-2026) Table 106. North America SGLT2 Inhibitor Sales Forecast by Country (2027-2032) & (kg) Table 107. North America SGLT2 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 108. North America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America SGLT2 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 110. North America SGLT2 Inhibitor Market Share by Country (2021-2026) Table 111. North America SGLT2 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America SGLT2 Inhibitor Market Share Forecast by Country (2027-2032) Table 113. Europe SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 114. Europe SGLT2 Inhibitor Sales by Country (2021-2026) & (kg) Table 115. Europe SGLT2 Inhibitor Sales Market Share by Country (2021-2026) Table 116. Europe SGLT2 Inhibitor Sales Forecast by Country (2027-2032) & (kg) Table 117. Europe SGLT2 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 118. Europe SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe SGLT2 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe SGLT2 Inhibitor Market Share by Country (2021-2026) Table 121. Europe SGLT2 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe SGLT2 Inhibitor Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific SGLT2 Inhibitor Sales by Country (2021-2026) & (kg) Table 125. Asia-Pacific SGLT2 Inhibitor Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific SGLT2 Inhibitor Sales Forecast by Country (2027-2032) & (kg) Table 127. Asia-Pacific SGLT2 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific SGLT2 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific SGLT2 Inhibitor Market Share by Country (2021-2026) Table 131. Asia-Pacific SGLT2 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific SGLT2 Inhibitor Market Share Forecast by Country (2027-2032) Table 133. Latin America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 134. Latin America SGLT2 Inhibitor Sales by Country (2021-2026) & (kg) Table 135. Latin America SGLT2 Inhibitor Sales Market Share by Country (2021-2026) Table 136. Latin America SGLT2 Inhibitor Sales Forecast by Country (2027-2032) & (kg) Table 137. Latin America SGLT2 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America SGLT2 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America SGLT2 Inhibitor Market Share by Country (2021-2026) Table 141. Latin America SGLT2 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America SGLT2 Inhibitor Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa SGLT2 Inhibitor Sales by Country (2021-2026) & (kg) Table 145. Middle East and Africa SGLT2 Inhibitor Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa SGLT2 Inhibitor Sales Forecast by Country (2027-2032) & (kg) Table 147. Middle East and Africa SGLT2 Inhibitor Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa SGLT2 Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa SGLT2 Inhibitor Market Share by Country (2021-2026) Table 151. Middle East and Africa SGLT2 Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa SGLT2 Inhibitor Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. SGLT2 Inhibitor Distributors List Table 156. SGLT2 Inhibitor Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. SGLT2 Inhibitor Image Figure 2. Global SGLT2 Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SGLT2 Inhibitor Market Size (2021-2032) & (US$ Million) Figure 4. Global SGLT2 Inhibitor Sales (2021-2032) & (kg) Figure 5. Dapagliflozin Image Figure 6. Global Dapagliflozin Sales YoY Growth (2021-2032) & (kg) Figure 7. Empagliflozin Image Figure 8. Global Empagliflozin Sales YoY Growth (2021-2032) & (kg) Figure 9. Canagliflozin Image Figure 10. Global Canagliflozin Sales YoY Growth (2021-2032) & (kg) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (kg) Figure 13. Global SGLT2 Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global SGLT2 Inhibitor Market Share by Type 2025 VS 2032 Figure 15. North America SGLT2 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 16. North America SGLT2 Inhibitor Sales Market Share in Value by Type in 2025 Figure 17. Europe SGLT2 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 18. Europe SGLT2 Inhibitor Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific SGLT2 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific SGLT2 Inhibitor Sales Market Share in Value by Type in 2025 Figure 21. Latin America SGLT2 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 22. Latin America SGLT2 Inhibitor Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa SGLT2 Inhibitor Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa SGLT2 Inhibitor Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 SGLT2 Inhibitor Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 31. Global SGLT2 Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global SGLT2 Inhibitor Market Share by Application 2025 VS 2032 Figure 33. North America SGLT2 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 34. North America SGLT2 Inhibitor Sales Market Share in Value by Application in 2025 Figure 35. Europe SGLT2 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 36. Europe SGLT2 Inhibitor Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific SGLT2 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific SGLT2 Inhibitor Sales Market Share in Value by Application in 2025 Figure 39. Latin America SGLT2 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 40. Latin America SGLT2 Inhibitor Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa SGLT2 Inhibitor Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa SGLT2 Inhibitor Sales Market Share in Value by Application in 2025 Figure 43. North America SGLT2 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. North America SGLT2 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America SGLT2 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America SGLT2 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe SGLT2 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Europe SGLT2 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe SGLT2 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe SGLT2 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific SGLT2 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Asia-Pacific SGLT2 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific SGLT2 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific SGLT2 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America SGLT2 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Latin America SGLT2 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America SGLT2 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America SGLT2 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa SGLT2 Inhibitor Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 60. Middle East and Africa SGLT2 Inhibitor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa SGLT2 Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa SGLT2 Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. SGLT2 Inhibitor Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. SGLT2 Inhibitor Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dapagliflozin
  • Empagliflozin
  • Canagliflozin
  • Other
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • Pfizer
  • AstraZeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SGLT2 Inhibitor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global SGLT2 Inhibitor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 SGLT2 Inhibitor Market by Type
  6. 1.3.1 Dapagliflozin
  7. 1.3.2 Empagliflozin
  8. 1.3.3 Canagliflozin
  9. 1.3.4 Other
  10. 1.4 Global SGLT2 Inhibitor Market Size by Type
  11. 1.4.1 Global SGLT2 Inhibitor Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global SGLT2 Inhibitor Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global SGLT2 Inhibitor Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America SGLT2 Inhibitor Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe SGLT2 Inhibitor Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific SGLT2 Inhibitor Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America SGLT2 Inhibitor Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa SGLT2 Inhibitor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 SGLT2 Inhibitor Industry Trends
  2. 2.2 SGLT2 Inhibitor Industry Drivers
  3. 2.3 SGLT2 Inhibitor Industry Opportunities and Challenges
  4. 2.4 SGLT2 Inhibitor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by SGLT2 Inhibitor Revenue (2021-2026)
  2. 3.2 Global Top Players by SGLT2 Inhibitor Sales (2021-2026)
  3. 3.3 Global Top Players by SGLT2 Inhibitor Price (2021-2026)
  4. 3.4 Global SGLT2 Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global SGLT2 Inhibitor Major Company Production Sites & Headquarters
  6. 3.6 Global SGLT2 Inhibitor Company, Product Type & Application
  7. 3.7 Global SGLT2 Inhibitor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global SGLT2 Inhibitor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 SGLT2 Inhibitor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 SGLT2 Inhibitor Tier 1, Tier 2, and Tier 3
4 SGLT2 Inhibitor Regional Status and Outlook
  1. 4.1 Global SGLT2 Inhibitor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global SGLT2 Inhibitor Historic Market Size by Region
  3. 4.2.1 Global SGLT2 Inhibitor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global SGLT2 Inhibitor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global SGLT2 Inhibitor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global SGLT2 Inhibitor Forecasted Market Size by Region
  7. 4.3.1 Global SGLT2 Inhibitor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global SGLT2 Inhibitor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global SGLT2 Inhibitor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 SGLT2 Inhibitor by Application
  1. 5.1 SGLT2 Inhibitor Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.2 Global SGLT2 Inhibitor Market Size by Application
  5. 5.2.1 Global SGLT2 Inhibitor Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global SGLT2 Inhibitor Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global SGLT2 Inhibitor Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America SGLT2 Inhibitor Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe SGLT2 Inhibitor Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific SGLT2 Inhibitor Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America SGLT2 Inhibitor Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa SGLT2 Inhibitor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson SGLT2 Inhibitor Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck SGLT2 Inhibitor Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly SGLT2 Inhibitor Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer SGLT2 Inhibitor Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca SGLT2 Inhibitor Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim SGLT2 Inhibitor Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America SGLT2 Inhibitor Sales by Country
  2. 7.1.1 North America SGLT2 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America SGLT2 Inhibitor Sales by Country (2021-2026)
  4. 7.1.3 North America SGLT2 Inhibitor Sales Forecast by Country (2027-2032)
  5. 7.2 North America SGLT2 Inhibitor Market Size by Country
  6. 7.2.1 North America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America SGLT2 Inhibitor Market Size by Country (2021-2026)
  8. 7.2.3 North America SGLT2 Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe SGLT2 Inhibitor Sales by Country
  2. 8.1.1 Europe SGLT2 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe SGLT2 Inhibitor Sales by Country (2021-2026)
  4. 8.1.3 Europe SGLT2 Inhibitor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe SGLT2 Inhibitor Market Size by Country
  6. 8.2.1 Europe SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe SGLT2 Inhibitor Market Size by Country (2021-2026)
  8. 8.2.3 Europe SGLT2 Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific SGLT2 Inhibitor Sales by Country
  2. 9.1.1 Asia-Pacific SGLT2 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific SGLT2 Inhibitor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific SGLT2 Inhibitor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific SGLT2 Inhibitor Market Size by Country
  6. 9.2.1 Asia-Pacific SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific SGLT2 Inhibitor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific SGLT2 Inhibitor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America SGLT2 Inhibitor Sales by Country
  2. 10.1.1 South America SGLT2 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America SGLT2 Inhibitor Sales by Country (2021-2026)
  4. 10.1.3 South America SGLT2 Inhibitor Sales Forecast by Country (2027-2032)
  5. 10.2 South America SGLT2 Inhibitor Market Size by Country
  6. 10.2.1 South America SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America SGLT2 Inhibitor Market Size by Country (2021-2026)
  8. 10.2.3 South America SGLT2 Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa SGLT2 Inhibitor Sales by Country
  2. 11.1.1 Middle East and Africa SGLT2 Inhibitor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa SGLT2 Inhibitor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa SGLT2 Inhibitor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa SGLT2 Inhibitor Market Size by Country
  6. 11.2.1 Middle East and Africa SGLT2 Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa SGLT2 Inhibitor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa SGLT2 Inhibitor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 SGLT2 Inhibitor Value Chain Analysis
  2. 12.1.1 SGLT2 Inhibitor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 SGLT2 Inhibitor Production Mode & Process
  7. 12.2 SGLT2 Inhibitor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 SGLT2 Inhibitor Distributors
  10. 12.2.3 SGLT2 Inhibitor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst